The relationship between microRNA-126 and maintenance therapy with bevacizumab after bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study.
Torben Hansen
Research Funding - Roche/Genentech
Rene dePont Christensen
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Rikke Fredslund Andersen
No relevant relationships to disclose
Karen-Lise Garm Spindler
No relevant relationships to disclose
Flemming Brandt Soerensen
No relevant relationships to disclose
Anders Johnsson
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech (I)
Other Remuneration - Roche/Genentech
Anders Kristian Moeller Jakobsen
Research Funding - Roche